Ask AI
ProCE Banner Activity

Convenience and Choice Are Not Enough: Treatment Highlights From AIDS 2026

Conference Coverage
Clinical Thought

New treatments are promising convenience and choice for people living with HIV. But in order to truly rethink, rebuild, and rise to tackle HIV—the theme from the AIDS 2026 conference—we need to ensure access to these treatments.

Released: August 25, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

This activity is supported through independent educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

Partners

International AIDS Society

ProCE Banner

Target Audience

This program is intended for physicians, pharmacists, registered nurses, and other healthcare professionals who care for people living with or at risk of HIV infection.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Integrate the latest scientific findings to develop and optimize effective HIV prevention interventions

Financial Disclosures

Primary Author

Tristan J. Barber, MA, MD, FRCP: consultant/advisor/speaker: Gilead, Johnson & Johnson, Merck, Novo Nordisk, ViiV/GSK.